4//SEC Filing
Coley Pharmaceutical Group, Inc. 4
Accession 0001181431-05-047432
CIK 0001319197operating
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 12:31 PM ET
Size
15.1 KB
Accession
0001181431-05-047432
Insider Transaction Report
Form 4
Bratzler Robert L
DirectorPresident and CEO
Transactions
- Conversion
Common Stock
2005-08-15+104,039→ 150,654 total(indirect: By Trust) - Conversion
Common Stock
2005-08-15+73,360→ 308,697 total - Conversion
Series G Convertible Preferred Stock
2005-08-15−476,500→ 0 total(indirect: By Trust)Exercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (104,039 underlying) - Conversion
Series G Convertible Preferred Stock
2005-08-15−335,993→ 0 totalExercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (73,360 underlying)
Footnotes (1)
- [F1]The shares of Series G Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
Issuer
Coley Pharmaceutical Group, Inc.
CIK 0001319197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001319197
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 12:31 PM ET
- Size
- 15.1 KB